Bone Marrow Transplant Clinical Trials - CSL Behring CSL964_2001
Bone marrow transplant
Status:Open (Study open and enrolling)
CONDITION(S): Graft Versus Host Disease - TRIAL: CSL Behring CSL964_2001 - The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant (MODULAATE).
This study is a Phase 2/3 prospective, double-blind, randomized, multi-center, placebo‑controlled study for prevention of acute GVHD (aGVHD) in subjects undergoing an allogeneic hematopoietic cell transplant (HCT).